EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Estimating the Effects of Continuous Albuterol Dosage on Clinical Outcomes for Pediatric Critical Asthma Exacerbation: A Retrospective Cohort Study

Daniel P Riggins iD, Eneida A Mendonca, Lucas Bulgarelli, Patricia Tachinardi, Wanzhu Tu, Colin Rogerson iD

Pediatric Pulmonology · 2025

DOI: 10.1002/ppul.71293 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Daniel P Riggins und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Albuterol, Asthma, Bronchodilator Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pediatric asthma exacerbations sometimes require aggressive intervention including continuous albuterol, a cornerstone therapy for reversing airway obstruction. However, pediatric dosing typically follows adult guidelines, with limited evidence for specific dosing ranges. This study aimed to compare the clinical outcomes of a reduced initial dose (10 mg/h) of continuous albuterol with a standard dose (15 mg/h) in children hospitalized for critical asthma exacerbations.

Methods

This retrospective cohort study was conducted at Riley Hospital for Children, analyzing pediatric patients (ages: 2–18) admitted with critical asthma exacerbations between 2014 and 2022. Stabilized inverse probability weighting (SIPW) was used to adjust for confounding factors between groups. The primary outcome was the percentage change in the Pediatric Asthma Severity Score (PASS) at 24 h, with secondary outcomes including the duration of continuous albuterol, PICU length of stay, and hospital length of stay.

Results

Analysis of 1,486 encounters revealed no significant difference in percent PASS changes at 24 h between the 10 mg/h and 15 mg/h groups (Additive Treatment Effect of 1.69, 95% CI: −0.93–4.31, p = 0.207). PICU and hospital lengths of stay were also similar. However, the 10 mg/h group showed a significantly shorter duration of continuous albuterol therapy compared to the 15 mg/h group (Multiplicative Treatment Effect of 1.29, 95% CI: 1.14–1.45, p < 0.001).

Conclusions

Findings suggest that starting continuous albuterol at 10 mg/h provides clinical outcomes comparable to 15 mg/h in managing pediatric critical asthma exacerbations. A lower starting dose may optimize resource use and reduce treatment‐related adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuterolAsthmaBronchodilator AgentsHumansRetrospective StudiesChildFemaleMaleChild, PreschoolAdolescentTreatment OutcomeLength of StaySeverity of Illness IndexDose-Response Relationship, DrugDisease Progression

Substanzen

AlbuterolBronchodilator Agents

Autor:innen und Institutionen

  • Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA.
  • Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA.
  • Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Department of Biostatistics & Health Data Sciences, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
  • Indiana University Center for Aging Research, Regenstrief Institute, Indianapolis, Indiana, USA.

ORCID-Profile: Daniel P Riggins, Colin Rogerson

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Riggins, D. P., Mendonca, E. A., Bulgarelli, L., Tachinardi, P., Tu, W., & Rogerson, C. (2025). Estimating the Effects of Continuous Albuterol Dosage on Clinical Outcomes for Pediatric Critical Asthma Exacerbation: A Retrospective Cohort Study. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71293

Vancouver

Riggins DP, Mendonca EA, Bulgarelli L, Tachinardi P, Tu W, Rogerson C. Estimating the Effects of Continuous Albuterol Dosage on Clinical Outcomes for Pediatric Critical Asthma Exacerbation: A Retrospective Cohort Study. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71293

BibTeX
@article{Riggins2025,
  author = {Riggins, Daniel P and Mendonca, Eneida A and Bulgarelli, Lucas and Tachinardi, Patricia and Tu, Wanzhu and Rogerson, Colin},
  title = {Estimating the Effects of Continuous Albuterol Dosage on Clinical Outcomes for Pediatric Critical Asthma Exacerbation: A Retrospective Cohort Study},
  journal = {Pediatric Pulmonology},
  year = {2025},
  doi = {10.1002/ppul.71293}
}
Kostenlos starten →